scorecardresearch
Friday, March 29, 2024
Support Our Journalism
HomeHealthUP managed to control Encephalitis by 75%, fatality rate reduced to 95%,...

UP managed to control Encephalitis by 75%, fatality rate reduced to 95%, says CM Adityanath

Adityanath said that after coming to power in 2017, the government started a special campaign to control the disease.

Follow Us :
Text Size:

Varanasi: Uttar Pradesh managed to control the Encephalitis disease by 75 per cent and the fatality rate due to it has reduced by 95 per cent in the past four years, said Chief Minister Yogi Adityanath on Sunday.

While inaugurating a campaign here to create awareness about communicable diseases, Adityanath said, “In 2017, we started a special vaccination programme to aware citizens about Encephalitis. As a result, the state managed to control the disease by 75 per cent and the death rate due to the disease reduced by 95 per cent in the past four years.” “We will fully control the disease in coming years. United Nations International Children’s Emergency Fund (UNICEF), World Health Organization (WHO) also supported to make this program a success,” he added.

The campaign will formally start from March 1 and will continue till March 31.
Adityanath said that after coming to power in 2017, the government started a special campaign to control Encephalitis disease. “We formed special teams for treatment and controlling the disease,” he said.

Last week, Adityanath launched the Japanese encephalitis (JE) vaccine drive and administered the vaccine drops to children in Lucknow.


Also read: India registers 16,752 new Covid cases, highest single-day jump in 30 days


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular